VYNE Therapeutics Inc. - COM (VYNE)

Historical Portfolio Holders from Q1 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
7.94M
Holdings value Q2 2024
$16M
Value change Q2 2024
+$243K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
29
Number of buys Q2 2024
14
Number of sells Q2 2024
-11
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 7.94M $16M +$243K $1.97 29
2024 Q1 6.4M $19.7M +$378K $3.07 28
2023 Q4 7.86M $18.3M +$17.2M $2.33 31
2023 Q3 359K $1.44M -$33.7K $4.04 19
2023 Q2 375K $1.53M +$198K $4.10 18
2023 Q1 334K $1.03M +$1.03M $3.08 18